Holdings over time
(Since January 1, 2022)
Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
---|---|---|---|---|
Vaxcyte (PCVX) | 14.73% | 0% | 99.91% | 2/1/2025 |
Catalyst Pharmaceuticals (CPRX) | 14.32% | 0% | 99.91% | 2/1/2025 |
Dynavax (DVAX) | 11.15% | 0% | 99.91% | 2/1/2025 |
OutSmartNSDQ | 7.91% | 0% | 99.91% | 2/1/2025 |
Rolls-Royce (RR.L) | 7.76% | 0% | 99.91% | 2/1/2025 |
Meta (META) | 3.88% | 0% | 96.26% | 2/1/2025 |
Card Factory (CARD.L) | 3.74% | 0% | 99.91% | 2/1/2025 |
XRP (XRP) | 3.41% | 0% | 99.91% | 2/1/2025 |
Seanergy (SHIP) | 3.01% | 0% | 99.91% | 2/1/2025 |
Vaxart (VXRT) | 2.45% | 0% | 99.91% | 2/1/2025 |
Energy Transfer (ET) | 1.89% | 0% | 31.02% | 12/28/2022 |
Beyond (BYON) | 1.8% | 0% | 99.91% | 2/1/2025 |
Agenus (AGEN) | 1.77% | 0% | 99.91% | 2/1/2025 |
Nio (NIO) | 1.64% | 0% | 99.91% | 2/1/2025 |
Co-Diagnostics (CODX) | 1.59% | 0% | 99.91% | 2/1/2025 |
Aldeyra (ALDX) | 1.42% | 0% | 99.91% | 2/1/2025 |
Gossamer Bio (GOSS) | 1.32% | 0% | 99.91% | 2/1/2025 |
Boxlight (BOXL) | 1.31% | 0% | 99.91% | 2/1/2025 |
iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) | 1.16% | 0% | 99.91% | 2/1/2025 |
Lockheed Martin (LMT) | 1.16% | 0% | 99.91% | 2/1/2025 |
Merck (MRK) | 1.16% | 0% | 99.91% | 2/1/2025 |
Moody's (MCO) | 1.11% | 0% | 99.91% | 2/1/2025 |
Scorpius Holdings (SCPX) | 1.06% | 0% | 99.91% | 2/1/2025 |
Cleanspark (CLSK) | 0.95% | 0% | 99.91% | 2/1/2025 |
Kartoon Studios (TOON) | 0.7% | 0% | 99.91% | 2/1/2025 |
Zynerba Pharmaceuticals Inc (ZYNE) | 0.62% | 0% | 57.12% | 10/18/2023 |
Bluebird Bio (BLUE) | 0.62% | 0% | 99.91% | 2/1/2025 |
Remark Holdings (MARK) | 0.48% | 0% | 99.91% | 2/1/2025 |
Cocrystal Pharma (COCP) | 0.44% | 0% | 99.91% | 2/1/2025 |
SiNtx (SINT) | 0.27% | 0% | 66.61% | 1/30/2024 |
Aytu BioScience (AYTU) | 0.24% | 0% | 99.91% | 2/1/2025 |
NEO (NEO) | 0.23% | 0% | 99.91% | 2/1/2025 |
HTG Molecular Diagnostics Inc (HTGMQ) | 0.23% | 0% | 62.77% | 12/20/2023 |
Sorrento (SRNE) | 0.21% | 0% | 70.35% | 4/19/2024 |
Evofem Biosciences (EVFM) | 0.12% | 0% | 41.15% | 5/1/2023 |
ToughBuilt (TBLT) | 0.09% | 0% | 65.33% | 1/17/2024 |
Pacific Biosciences (PACB) | 0.08% | 0% | 27.55% | 2/1/2025 |
Scilex (SCLX) | 0.08% | 0% | 66.51% | 2/1/2025 |
Caribou Biosciences (CRBU) | 0.07% | 0% | 27.55% | 2/1/2025 |
Athenex Inc (ATNXQ) | 0.06% | 0% | 43.98% | 5/23/2023 |
Agile Therapeutics (AGRX) | 0.04% | 0% | 40.42% | 4/14/2023 |
Mink Therapeutics (INKT) | 0.01% | 0% | 57.85% | 2/1/2025 |
Zynerba Pharmaceuticals, Inc. CVR (ZYNE.CVR) | 0% | 0% | 0% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
Instrument | Invested | Value |
---|---|---|
Vaxcyte (PCVX) | 4.51% | 18.61% |
Catalyst Pharmaceuticals (CPRX) | 2.25% | 16.74% |
Rolls-Royce (RR.L) | 2.25% | 14.36% |
Dynavax (DVAX) | 4.62% | 9.29% |
XRP (XRP) | 2.25% | 9.08% |
OutSmartNSDQ | 5.27% | 7.86% |
Meta (META) | 1.82% | 5.95% |
Vaxart (VXRT) | 7.89% | 3.44% |
Card Factory (CARD.L) | 1.01% | 3.43% |
Seanergy (SHIP) | 4.51% | 2.18% |
Moody's (MCO) | 0.56% | 1.18% |
Aldeyra (ALDX) | 2.25% | 1.05% |
Lockheed Martin (LMT) | 0.56% | 0.97% |
iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) | 0.9% | 0.9% |
Cleanspark (CLSK) | 2.25% | 0.89% |
Merck (MRK) | 0.56% | 0.86% |
Nio (NIO) | 3.49% | 0.51% |
Co-Diagnostics (CODX) | 4.51% | 0.37% |
Beyond (BYON) | 2.93% | 0.29% |
Pacific Biosciences (PACB) | 0.41% | 0.27% |
Cocrystal Pharma (COCP) | 2.25% | 0.24% |
Gossamer Bio (GOSS) | 2.25% | 0.24% |
NEO (NEO) | 0.9% | 0.21% |
Caribou Biosciences (CRBU) | 0.4% | 0.17% |
Agenus (AGEN) | 2.37% | 0.13% |
Boxlight (BOXL) | 4.51% | 0.13% |
Kartoon Studios (TOON) | 2.25% | 0.09% |
Bluebird Bio (BLUE) | 3.94% | 0.06% |
Aytu BioScience (AYTU) | 4.51% | 0.05% |
Remark Holdings (MARK) | 3.36% | 0.02% |
Scorpius Holdings (SCPX) | 4.51% | 0.01% |
Mink Therapeutics (INKT) | 0% | 0.01% |
Scilex (SCLX) | 0% | 0.01% |
ToughBuilt (TBLT) | 2.25% | 0% |
Sorrento (SRNE) | 2.25% | 0% |
SiNtx (SINT) | 2.25% | 0% |
HTG Molecular Diagnostics Inc (HTGMQ) | 2.3% | 0% |
Evofem Biosciences (EVFM) | 4.51% | 0% |
Zynerba Pharmaceuticals, Inc. CVR (ZYNE.CVR) | 0% | 0% |